Novartis acquires Avidity in a $12B bet on RNA therapeutics for rare disease. A landmark deal in biopharma M&A and drug ...

CSL delays its spin-off and cuts profit guidance as declining vaccination rates and market demand challenge the biotech ...

The US stillbirth rate is higher than reported, revealing critical gaps in maternal health and healthcare equity. An analysis ...

BioMarin to divest its gene therapy unit, a major portfolio optimization move reflecting challenges in the rare disease ...

Compare the top trading terminals for active traders in 2025. Discover which platforms offer the best performance, tools, and analytics to help you trade smarter and stay ahead in fast-moving markets.

Industry expert Mitchell Kennedy explores the most common operational challenges restaurants face today — from staffing and ...

In 2025, 65 percent of American adults used digital wallets, and one year earlier, that figure was 57 percent, which shows ...